Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
5.6
75.87%
40%
—
348.54%
80%
—
5 Years
Score5.6
Net Growth75.87%
Net Trend40%
Net Income Consistency—
Rev Growth348.54%
Rev Trend80%
Revenue Consistency—
Travere Therapeutics Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 198M to $ 490M and net income went from -$ 169M to -$ 25M. Revenue increased in 4 of those 5 years; net income in 2.
Between 2015 and 2025, revenue grew from $ 99M to $ 490M and net income went from $ 117M to -$ 25M. Revenue increased in 8 of those 10 years; net income in 2.
Travere Therapeutics Inc currently holds a 5-year HDB Score of 5.6 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 62.16 | — |
1 Year2025-08-12 | $ 17.41 | 257.04% |
5 Years2021-08-12 | $ 15.12 | 311.11% |
10 Years2016-08-12 | $ 17.33 | 258.68% |
20 Years2006-08-11 | $ 4.50 | 13x |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 |
|---|---|---|---|---|---|
| Price | $ 62.16 | $ 17.41 | $ 15.12 | $ 17.33 | $ 4.50 |
| Return | — | 257.04% | 311.11% | 258.68% | 13x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 591M | -$ 43M | $ 489M |
| 2025 | $ 490M | -$ 25M | $ 322M |
| 2024 | $ 233M | -$ 321M | $ 370M |
| 2023 | $ 145M | -$ 111M | $ 566M |
| 2022 | $ 109M | -$ 278M | $ 450M |
| 2021 | $ 131M | -$ 180M | $ 552M |
| 2020 | $ 198M | -$ 169M | $ 361M |
| 2019 | $ 175M | -$ 146M | $ 398M |
| 2018 | $ 164M | -$ 102M | $ 471M |
| 2017 | $ 154M | -$ 59M | $ 300M |
| 2016 | $ 133M | -$ 47M | $ 255M |
| 2015 | $ 99M | $ 117M | $ 229M |
| 2014 | $ 28M | -$ 110M | $ 27M |
| 2013 | -$ 33M | $ 6M | |
| IPO2012 | -$ 30M | $ 11.39K |
Explore beyond TVTX
You're looking at Travere Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
